NIEL, Belgium, March 28, 2022 (GLOBE NEWSWIRE) -- eTheRNA Manufacturing, a specialist RNA process developer and manufacturing member of the Belgian eTheRNA group, is introducing a new Lipid ...
Unique solutions are required to protect inherently unstable messenger RNA. Oligonucleotide drug substances generally are unstable at room temperature, and some are also degraded in the presence of ...
The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...
Drug development often progresses from one phase to the next without considering long-term feasibility, such as scalability, cost-effectiveness, and market access. Sustainable success is assured by ...
Stay ahead in the rapidly evolving LNP space with the 4 th LNP Formulation & Process Development Summit - the largest global meeting dedicated purely to LNPs. The official event guide is your ...
WuXi STA, a subsidiary of WuXi AppTec, reports that a new parenteral formulation manufacturing line has started operation at the drug product site in Wuxi city, China. It is the second line opened ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results